Your browser doesn't support javascript.
loading
Very long-term efficacy of venetoclax combined with hypomethylating agents in two AML elderly: is it the time for treatment discontinuation strategies?
Niscola, Pasquale; Gianfelici, Valentina; Giovannini, Marco; Piccioni, Daniela; Mazzone, Carla; Fabritiis, Paolo de.
Afiliação
  • Niscola P; Hematology Unit, Sant 'Eugenio Hospital of Rome, ASL Roma 2, Rome, Italy. pniscola@gmail.com.
  • Gianfelici V; Hematology Unit, Sant 'Eugenio Hospital of Rome, ASL Roma 2, Rome, Italy.
  • Giovannini M; Hematology Unit, Sant 'Eugenio Hospital of Rome, ASL Roma 2, Rome, Italy.
  • Piccioni D; Hematology Unit, Sant 'Eugenio Hospital of Rome, ASL Roma 2, Rome, Italy.
  • Mazzone C; Hematology Unit, Sant 'Eugenio Hospital of Rome, ASL Roma 2, Rome, Italy.
  • Fabritiis P; Hematology Unit, Sant 'Eugenio Hospital of Rome, ASL Roma 2, Rome, Italy.
Ann Hematol ; 103(5): 1787-1788, 2024 May.
Article em En | MEDLINE | ID: mdl-38459155

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sulfonamidas / Azacitidina / Leucemia Mieloide Aguda Limite: Aged / Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sulfonamidas / Azacitidina / Leucemia Mieloide Aguda Limite: Aged / Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article